Business · 12/03/2024Updated: 10/17/2026 · 1 min read
FDA Seeks Public Comment on Proposed Collection of Information for Human Blood and Blood Products Manufacturers
Summary
The Food and Drug Administration is requesting public comment on proposed regulations requiring human blood and blood products manufacturers to register and list their products, in accordance with the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →